The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.
Domenighetti, Cloé Douillard, Venceslas Sugier, Pierre-Emmanuel Sreelatha, Ashwin Ashok Kumar Schulte, Claudia Grover, Sandeep May, Patrick Bobbili, Dheeraj R Radivojkov-Blagojevic, Milena Lichtner, Peter
Domenighetti, Cloé
Douillard, Venceslas
Sugier, Pierre-Emmanuel
Sreelatha, Ashwin Ashok Kumar
Schulte, Claudia
Grover, Sandeep
May, Patrick
Bobbili, Dheeraj R
Radivojkov-Blagojevic, Milena
Lichtner, Peter
Citations
Altmetric:
Affiliation
Université Paris-Saclay; Nantes Université; University of Tubingen; Sandwell West Birmingham NHS Trust
Other Contributors
Publication date
2022-07-10
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Two studies that examined the interaction between HLA-DRB1 and smoking in Parkinson's disease (PD) yielded findings in opposite directions.
Objective: To perform a large-scale independent replication of the HLA-DRB1 × smoking interaction.
Methods: We genotyped 182 single nucleotide polymorphism (SNPs) associated with smoking initiation in 12 424 cases and 9480 controls to perform a Mendelian randomization (MR) analysis in strata defined by HLA-DRB1.
Results: At the amino acid level, a valine at position 11 (V11) in HLA-DRB1 displayed the strongest association with PD. MR showed an inverse association between genetically predicted smoking initiation and PD only in absence of V11 (odds ratio, 0.74, 95% confidence interval, 0.59-0.93, PInteraction = 0.028). In silico predictions of the influence of V11 and smoking-induced modifications of α-synuclein on binding affinity showed findings consistent with this interaction pattern.
Conclusions: Despite being one of the most robust findings in PD research, the mechanisms underlying the inverse association between smoking and PD remain unknown. Our findings may help better understand this association. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Citation
Domenighetti C, Douillard V, Sugier PE, Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Gourraud PA, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Ygland Rödström E, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Vince N, Elbaz A; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) Consortium. The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited. Mov Disord. 2022 Sep;37(9):1929-1937. doi: 10.1002/mds.29133.
Type
Article